Invivyd Inc IVVD:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/04/22 EDT
3.35quote price arrow up+0.11 (+3.40%)
Volume
461,989
52 week range
2.41 - 78.82
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.35
  • 52 Week High78.82
  • 52 Week High Date11/30/21
  • 52 Week Low2.41
  • 52 Week Low Date06/15/22

Key Stats

  • Market Cap364.58M
  • Shares Out108.83M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.86

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.35
  • 52 Week High78.82
  • 52 Week High Date11/30/21
  • 52 Week Low2.41
  • 52 Week Low Date06/15/22
  • Market Cap364.58M
  • Shares Out108.83M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.86

RATIOS/PROFITABILITY

  • EPS (TTM)-3.15
  • P/E (TTM)-1.06
  • Fwd P/E (NTM)-2.12
  • EBITDA (TTM)-295.986M
  • ROE (TTM)-218.40%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Invivyd Inc

 

Profile

MORE
Invivyd, Inc., formerly Adagio Therapeutics, Inc., is a biopharmaceutical company. The company is engaged in developing antibodies to transcend the limits of naturally occurring immunity and provide protection from viral diseases, beginning with COVID-19. Its technology works at the intersection of virology, predictive modeling, and antibody engineering. Its platform approach yields a pipeline of engineered antibodies designed to provide neutralization across past and current...
Marc Elia
Chairman of the Board
David Hering
Chief Executive Officer, Director
Jane Henderson
Chief Financial Officer, Chief Business Officer
Rebecca Dabora Ph.D.
Chief Technology and Manufacturing Officer
Address
1601 Trapelo Road, Suite 178
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ALLK
Allakos Inc
6.74+0.49+7.84%
BTAI
BioXcel Therapeutics Inc
12.46+0.92+7.97%
HUMA
Humacyte Inc
3.38+0.17+5.30%
KALV
Kalvista Pharmaceuticals Inc
5.85-8.39-58.92%
LXRX
Lexicon Pharmaceuticals Inc
2.56+0.11+4.49%